BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2018
View Archived Issues
Targeting GPCR prevents pre-eclampsia
Read More
Eli Lilly initiates phase I study of its bispecific antibody LY-3415244
Read More
Open-source drug discovery yields malaria prevention leads
Read More
Amgen presents first-in-human data for AMG-330 in relapsed/refractory AML
Read More
IMGN-632 demonstrates initial safety and activity in patients with AML and BPDCN
Read More
GMI-1687, a novel inhibitor of E-selectin with promising activity in preclinical models of AML
Read More
Icagen and Roche collaborate to develop and commercialize therapy for neurological diseases
Read More
Topline results presented from ENCORE-PH phase IIb study in patients with NASH cirrhosis
Read More
Phase I data presented for AUTO-3 CAR T-cell therapy targeting CD19 and CD22
Read More
Phase II study of elafibranor in primary biliary cholangitis meets primary endpoint
Read More
Multidomain antibodies with breadth and potency protect mice from a wide array of influenza strains
Read More
Novel thiazolidine free fatty acid FFA2 receptor agonist with improved properties
Read More
Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment
Read More
Phase III EAGLE trial of Imfinzi in head and neck cancer does not meet primary endpoints
Read More
FDA approves use of Tecentriq with Avastin and chemotherapy for first-line NSCLC
Read More
4D Molecular Therapeutics enters gene therapy collaboration for degenerative retinal diseases
Read More
Phase III pediatric ADHD studies with SPN-812 meet primary endpoint
Read More
Taizhou Huayuan Medicinal Tech patents brain damage resistance compounds
Read More
Prostanoid EP2 and/or EP4 receptor antagonists identified at Idorsia Pharmaceuticals
Read More
Phase III study of plinabulin for CIN meets primary endpoint at interim analysis
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine divulge TLR7 agonists
Read More
Mitobridge synthesizes new USP30 inhibitors
Read More
Biogen exercises option to obtain BIIB-067 from Ionis for ALS
Read More
Urate transporter 1 inhibitors patented by Hinova Pharmaceuticals
Read More
Low-dose aspirin protects from experimental autoimmune encephalomyelitis
Read More
AbbVie stops enrollment in Rova-T SCLC trial on IDMC recommendation
Read More
